Literature DB >> 1309833

Cortisol receptor resistance: the variability of its clinical presentation and response to treatment.

S W Lamberts1, J W Koper, P Biemond, F H den Holder, F H de Jong.   

Abstract

Primary (partial) cortisol receptor resistance was previously reported in a total of 7 patients and 14 asymptomatic family members. Its occurrence is considered to be extremely rare. In the present study we report on 6 patients (2 males and 4 females) with the syndrome. The first male patient presented with mild hypertension. Hydrochlorothiazide therapy resulted in life-threatening hypokalemia. The second male patient had slight hypertension without hypokalemia. All four female patients presented between the age of 20-30 yr with acne, hirsutism, and irregular menstruations. Low dose dexamethasone therapy (1-1.5 mg/day) was of clinical benefit in these patients. All patients showed insufficient suppression of serum cortisol concentrations in the overnight 1-mg dexamethasone test. The diurnal rhythm of ACTH and cortisol was intact, albeit at an elevated level. There was a normal increase in ACTH, cortisol, and GH (except in one obese patient) in response to insulin-induced hypoglycemia, while cortisol production was elevated in three patients. Circulating adrenal androgen levels were increased in all patients. Glucocorticoid receptors were investigated in a whole cell dexamethasone binding assay in mononuclear leukocytes. In the first male patient, the number of receptors was very low, while the affinity was lower than that in controls. A lowered affinity to dexamethasone was found in one female patient, while a lowered number of receptors was found in three patients. In the second male patient, no abnormalities were found. As a bioassay for glucocorticoid action we also measured dexamethasone suppressibility of mitogen-stimulated incorporation of [3H]thymidine in mononuclear leukocytes. In the male patient with normal receptor status, dexamethasone suppressibility of [3H]thymidine incorporation was significantly lower than that in healthy controls with respect to both maximal suppression and IC50. Partial cortisol receptor resistance might be less rare than previously thought. In the six patients presented, at least three different forms can be recognized. Therapy with dexamethasone was successful in female patients with acne and hirsutism, as the secondary increase in the production of adrenal androgens was effectively controlled.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309833     DOI: 10.1210/jcem.74.2.1309833

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Glucocorticoid and mineralocorticoid resistance.

Authors:  P A Komesaroff; M C Zennaro
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

2.  Clinical and biochemical impact of BCL1 polymorphic genotype of the glucocorticoid receptor gene in patients with adrenal incidentalomas.

Authors:  M Tzanela; E Mantzou; K Saltiki; M Tampourlou; N Kalogeris; D Hadjidakis; S Tsagarakis; M Alevizaki
Journal:  J Endocrinol Invest       Date:  2011-07-05       Impact factor: 4.256

3.  Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function.

Authors:  I Dijkstra; F J Tilders; G Aguilera; A Kiss; C Rabadan-Diehl; N Barden; S Karanth; F Holsboer; J M Reul
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

4.  Raised urinary glucocorticoid and adrenal androgen precursors in the urine of young hypertensive patients: possible evidence for partial glucocorticoid resistance.

Authors:  W Shamim; M Yousufuddin; D P Francis; P Gualdiero; J W Honour; S D Anker; A J Coats
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

5.  A case of severe hypertension caused by ACTH-independent macronodular adrenal hyperplasia.

Authors:  R Nocente; Marinis L De; A Mancini; A Bianchi; R Bellantone; L Lauriola; M Costanzo; Crea C De; G Gasbarrini; Silveri N Gentiloni
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

6.  Molecular screening for somatic mutations in corticotropic adenomas of dogs with pituitary-dependent hyperadrenocorticism.

Authors:  P A van Wijk; A Rijnberk; R J Croughs; B P Meij; I S van Leeuwen; E P Sprang; J A Mol
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

7.  A mutation of the glucocorticoid receptor in primary cortisol resistance.

Authors:  D M Malchoff; A Brufsky; G Reardon; P McDermott; E C Javier; C H Bergh; D Rowe; C D Malchoff
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness.

Authors:  G T Verhoeven; J P J J Hegmans; P G H Mulder; J M Bogaard; H C Hoogsteden; J-B Prins
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

9.  Human small cell lung cancer cell lines expressing the proopiomelanocortin gene have aberrant glucocorticoid receptor function.

Authors:  D W Ray; A C Littlewood; A J Clark; J R Davis; A White
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

10.  Inhibition of the production of mediators of inflammation by corticosteroids is a glucocorticoid receptor-mediated process.

Authors:  G S Madretsma; A P Dijk; C J Tak; J H Wilson; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.